Through its hypoglycemic actions and other distinct pathways, semaglutide also reduces appetite to facilitate weight loss
100% Bioavailability: This ensures that the full dose administered is available for the body to utilize immediately, which is often not the case with oral supplements
Tirzepatide is a GLP-1 and GIP receptor agonist that helps regulate blood sugar, decrease appetite, and promote weight loss
Zhou J, Huang W, Xie Y, Shen H, Liu M, Wu X (2025) Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database
Our clarity, stability, and customer support make a noticeable difference
Tirzepatide is generally recommended for individuals with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with weight related conditions like high blood pressure or high cholesterol